Neonates with intra-uterine growth delay represent more than 2% of the 800 000 annual births in France. Studies have shown that milks enriched with protein allow to accelerate newborns growth. According to some papers, growth acceleration would have a favourable effect on psycho-motor development at age of 2 or 3. However, for other authors, this would not lead to any benefit and even an early hyperproteinic feeding would have bad long term consequences such as appearance of several diseases in the future adult (overweight, diabetes, arterial hypertension, renal function alteration).The main objective of this clinical trial is to check that an hyperproteinic feeding does not lead to any benefit on psycho-motor development at age of 2, compared with a milk containing same level of protein than milk proposed to newborns of normal weight. The secondary objectives of our clinical trial are to compare the effects of these two types of milk on renal function, arterial blood pressure, body composition, corpulence, food preferences, insulin resistance and intestinal integrity at age of 2. A sub study will also be realized to analyse the proteic turn over . This sub-study will be undertaken only with neonates of Nantes Hospital.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
93
Neonates will drink the hyperproteinic milk until they reach the 25th of "Sempé and Pedron" curve (milk to be taken at least until 40 weeks of amenorrhoea or at maximum until 4 months of corrected age)
Neonates will drink the normoproteinic milk until they reach the 25th of "Sempé and Pedron" curve (milk to be taken at least until 40 weeks of amenorrhoea or at maximum until 4 months of corrected age)
Universitary Hospital
Nantes, France
Quotient of psycho-motor development evaluated by the Brunet-Lezine test at age of 2
Time frame: at 2 years old
Leptine, glycemia/insulin and pro-insulin blood level
Time frame: At age of 15 (+/- 2) days and at age of 2 years
Plasmatic and urinary citrulline levels
Time frame: At age of 15 (+/- 2) days and at age of 2 years
Micro-albuminuria, creatinine, urea, sodium and potassium urine levels
Time frame: At age of 15 (+/- 2) days and at age of 2 years
Faecal floa, faecal calprotectine and other markers
Time frame: At age of 15 (+/- 2) days and at age of 2 years
Arterial blood pressure, arterial elasticity, adiponectine, preferential food choices, kidney size
Time frame: at age of 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.